Financial Info

Financial Highlights  |  Ratios

Valuation P/E 23.95x   P/S 1.47x   P/B 2.29x   EPS 1461.17	Financial Strength Quick Ratio (MRQ) 0.58x   Current Ratio (MRQ) 1.11x   Total Debt/Equity (MRQ) 1.41x   Total Debt/Assets (MRQ) 0.59x	Operating Ratios Assets Turnover (TTM) 0.68x   Inventory Turnover (TTM) 1.79x   Receivables Turnover (TTM) 2.86x
Profitability Gross Margin (TTM) 30.57%   Operating Margin (TTM) 7.68%   EBIT Margin (TTM) 7.77%   Profit Margin (TTM) 6.15%	Management Effectiveness ROA (TTM) 4.18%   ROE (TTM) 10.87%   ROIC (TTM) 13.56%	Growth Rate Diluted EPS Growth (TTM) -23.95%   Sales Growth (TTM) 4.69%   Profit Growth (TTM) 0.57%   Asset Growth (TTM) 20.71%

MRQ: Most Recent Quarter    TTM: Trailing 12 Mon.    LFY: Last Fiscal Year

Compared to other companies in the same field, Agimexpharm Pharmaceutical Joint Stock Company is a small-scaled company in terms of assets, annual revenue, and owner equity. In terms of ROE, it ranks at number 4 out of 10 companies. The company has its own competitive edge in the market thanks...